New Two-Pronged attack on advanced cancers shows early promise
NCT ID NCT03468426
Summary
This early-stage study tested a new combination of two drugs, BI 836880 and ezabenlimab, in adults with advanced non-small cell lung cancer and other solid tumors. The first part aimed to find the safest dose. The second part then used that dose to see if the treatment could shrink tumors. The two drugs work together—one blocks the tumor's blood supply, while the other helps the immune system fight the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SQUAMOUS NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
Asan Medical Center
Seoul, 05505, South Korea
-
Beverly Hills Cancer Center
Beverly Hills, California, 90211, United States
-
CTR Eugène Marquis
Rennes, 35042, France
-
CTR Georges-François Leclerc
Dijon, 21079, France
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dom Lekarski S.A.
Szczecin, 70-784, Poland
-
European Health Center Otwock
Otwock, 05-462, Poland
-
HOP Civil
Strasbourg, 67091, France
-
HOP Nord Laennec
Saint-Herblain, 44800, France
-
HOP Timone
Marseille, 13385, France
-
Hospital Clinico Universitario De Valencia
Valencia, 46010, Spain
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Universitari Vall D Hebron
Barcelona, 08035, Spain
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
INS Curie
Paris, 75005, France
-
JSC "Group of Companies "Medsi"
Moscow, 125284, Russia
-
Kyiv City Clinical Oncological Center
Kyiv, 3115, Ukraine
-
MED POLONIA SP Z O O, Clinical Trials Department,Poznan
Poznan, 60-693, Poland
-
Mandziuk Slawomir Specialist Medical Practice
Lublin, 20-093, Poland
-
Medical and Preventive Treatment Inst. Volyn Regional, Lutsk
Lutsk, 43018, Ukraine
-
Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council
Dnipropetrovks, 49102, Ukraine
-
NCKUH
Tainan, 704, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Peninsula & South Eastern Oncology Group
Frankston, Victoria, 3199, Australia
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Royal Free Hospital
London, NW3 2QG, United Kingdom
-
Royal North Shore Hospital-St Leonards-20807
St Leonards, New South Wales, 2065, Australia
-
SBHI "Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncological)"
Saint Petersburg, 197758, Russia
-
Seoul National University Bundang Hospital
Seongnam, 13620, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
State Budget Healthcare Institution "Volgograd Regional Clinical Oncology Dispensary"
Volgograd, 400138, Russia
-
University Clinical Center, Gdansk
Gdansk, 80-952, Poland
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
Universitätsklinikum Augsburg
Augsburg, 86156, Germany
-
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, 01307, Germany
-
Universitätsklinikum Frankfurt
Frankfurt am Main, 60528, Germany
-
Universitätsklinikum Regensburg
Regensburg, 93053, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131, Germany
-
Vinnytsia Regional Clinical Oncological Dispensary
Vinnytsia, 21029, Ukraine
-
Virginia Cancer Specialists, PC
Fairfax, Virginia, 22031, United States
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
-
Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.